GSK profit lifted by HIV, asthma drugs in boost to new CEO
Its adjusted earnings per share rises to 25.5 pence, higher than analysts’ expectations reported better-than-expected profit in the fourth quarter, buoyed by its human…
Tag
GSK
GSK to buy US cancer biotech IDRx for up to US$1.15 billion
GSK agreed to buy US biotech IDRx for as much as US$1.15 billion to gain new cancer medicines. The UK drugmaker will pay US$1 billion upfront for IDRx, whose lead drug for gastrointestinal…
GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 billion
A drug currently sold under the name Zantac 360 uses a different active ingredient and contains no ranitidine 3 min read Last Updated : Oct 10 2024 | 10:02 AM IST GSK has agreed to pay up…